Perinatal respiratory infections and long term consequences

Respiratory syncytial virus (RSV) is the most important pathogen in the etiology of respiratory infections in early life. 50% of children are affected by RSV within the first year of age, and almost all children become infected within two years. Numerous retrospective and prospective studies linking...

Full description

Bibliographic Details
Main Authors: Luciana Indinnimeo, Valentina De Vittori
Format: Article
Language:English
Published: Hygeia Press di Corridori Marinella 2015-10-01
Series:Journal of Pediatric and Neonatal Individualized Medicine
Subjects:
Online Access:https://www.jpnim.com/index.php/jpnim/article/view/311
_version_ 1819014852902912000
author Luciana Indinnimeo
Valentina De Vittori
author_facet Luciana Indinnimeo
Valentina De Vittori
author_sort Luciana Indinnimeo
collection DOAJ
description Respiratory syncytial virus (RSV) is the most important pathogen in the etiology of respiratory infections in early life. 50% of children are affected by RSV within the first year of age, and almost all children become infected within two years. Numerous retrospective and prospective studies linking RSV and chronic respiratory morbidity show that RSV bronchiolitis in infancy is followed by recurrent wheezing after the acute episod. According to some authors a greater risk of wheezing in children with a history of RSV bronchiolitis would be limited to childhood, while according to others this risk would be extended into adolescence and adulthood. To explain the relationship between RSV infection and the development of bronchial asthma or the clinical pathogenetic patterns related to a state of bronchial hyperreactivity, it has been suggested that RSV may cause alterations in the response of the immune system (immunogenic hypothesis), activating directly mast cells and basophils and changing the pattern of differentiation of immune cells present in the bronchial tree as receptors and inflammatory cytokines. It was also suggested that RSV infection can cause bronchial hyperreactivity altering nervous airway modulation, acting on nerve fibers present in the airways (neurogenic hypothesis). The benefits of passive immunoprophylaxis with palivizumab, which seems to represent an effective approach in reducing the sequelae of RSV infection in the short- and long-term period, strengthen the implementation of prevention programs with this drug, as recommended by the national guidelines of the Italian Society of Neonatology.   Proceedings of the 11th International Workshop on Neonatology and Satellite Meetings · Cagliari (Italy) · October 26th-31st, 2015 · From the womb to the adult Guest Editors: Vassilios Fanos (Cagliari, Italy), Michele Mussap (Genoa, Italy), Antonio Del Vecchio (Bari, Italy), Bo Sun (Shanghai, China), Dorret I. Boomsma (Amsterdam, the Netherlands), Gavino Faa (Cagliari, Italy), Antonio Giordano (Philadelphia, USA)
first_indexed 2024-12-21T02:22:26Z
format Article
id doaj.art-177ed9485bd44ecda466139aacb22e99
institution Directory Open Access Journal
issn 2281-0692
language English
last_indexed 2024-12-21T02:22:26Z
publishDate 2015-10-01
publisher Hygeia Press di Corridori Marinella
record_format Article
series Journal of Pediatric and Neonatal Individualized Medicine
spelling doaj.art-177ed9485bd44ecda466139aacb22e992022-12-21T19:19:06ZengHygeia Press di Corridori MarinellaJournal of Pediatric and Neonatal Individualized Medicine2281-06922015-10-0142e040235e04023510.7363/040235253Perinatal respiratory infections and long term consequencesLuciana Indinnimeo0Valentina De Vittori1Department of Pediatrics and Pediatric Neuropsychiatry, “Sapienza” University of Rome, Rome, ItalyDepartment of Pediatrics and Pediatric Neuropsychiatry, “Sapienza” University of Rome, Rome, ItalyRespiratory syncytial virus (RSV) is the most important pathogen in the etiology of respiratory infections in early life. 50% of children are affected by RSV within the first year of age, and almost all children become infected within two years. Numerous retrospective and prospective studies linking RSV and chronic respiratory morbidity show that RSV bronchiolitis in infancy is followed by recurrent wheezing after the acute episod. According to some authors a greater risk of wheezing in children with a history of RSV bronchiolitis would be limited to childhood, while according to others this risk would be extended into adolescence and adulthood. To explain the relationship between RSV infection and the development of bronchial asthma or the clinical pathogenetic patterns related to a state of bronchial hyperreactivity, it has been suggested that RSV may cause alterations in the response of the immune system (immunogenic hypothesis), activating directly mast cells and basophils and changing the pattern of differentiation of immune cells present in the bronchial tree as receptors and inflammatory cytokines. It was also suggested that RSV infection can cause bronchial hyperreactivity altering nervous airway modulation, acting on nerve fibers present in the airways (neurogenic hypothesis). The benefits of passive immunoprophylaxis with palivizumab, which seems to represent an effective approach in reducing the sequelae of RSV infection in the short- and long-term period, strengthen the implementation of prevention programs with this drug, as recommended by the national guidelines of the Italian Society of Neonatology.   Proceedings of the 11th International Workshop on Neonatology and Satellite Meetings · Cagliari (Italy) · October 26th-31st, 2015 · From the womb to the adult Guest Editors: Vassilios Fanos (Cagliari, Italy), Michele Mussap (Genoa, Italy), Antonio Del Vecchio (Bari, Italy), Bo Sun (Shanghai, China), Dorret I. Boomsma (Amsterdam, the Netherlands), Gavino Faa (Cagliari, Italy), Antonio Giordano (Philadelphia, USA)https://www.jpnim.com/index.php/jpnim/article/view/311respiratory syncytial virusbronchiolitisimmune reactivitylunglong term consequencespalivizumab
spellingShingle Luciana Indinnimeo
Valentina De Vittori
Perinatal respiratory infections and long term consequences
Journal of Pediatric and Neonatal Individualized Medicine
respiratory syncytial virus
bronchiolitis
immune reactivity
lung
long term consequences
palivizumab
title Perinatal respiratory infections and long term consequences
title_full Perinatal respiratory infections and long term consequences
title_fullStr Perinatal respiratory infections and long term consequences
title_full_unstemmed Perinatal respiratory infections and long term consequences
title_short Perinatal respiratory infections and long term consequences
title_sort perinatal respiratory infections and long term consequences
topic respiratory syncytial virus
bronchiolitis
immune reactivity
lung
long term consequences
palivizumab
url https://www.jpnim.com/index.php/jpnim/article/view/311
work_keys_str_mv AT lucianaindinnimeo perinatalrespiratoryinfectionsandlongtermconsequences
AT valentinadevittori perinatalrespiratoryinfectionsandlongtermconsequences